Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check7 days agoChange DetectedFooter now shows Revision: v3.3.3 and no longer lists HHS Vulnerability Disclosure or Revision: v3.3.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRecord History now shows a new site revision entry: v3.3.2, updating from v3.2.0. This is a routine platform update; no changes to study details are apparent.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the government funding/operating status notice from the top of the page.SummaryDifference0.4%

- Check57 days agoChange DetectedNew screenshot shows additional version entries in the Record History and expanded Study Status/Contacts-Locations sections. The changes are administrative updates to the history view and do not modify core trial data such as eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0). The core impact is informing users about potential delays and where to check status.SummaryDifference9%

- Check93 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.